Homozygous expression of MHC-II alleles that confer susceptibility to type 1 diabetes limits the efficiency of thymic negative selection and allows for CXCR6+ pathogenic clones to orchestrate the disease process. Expression of a second MHC-II allele decreases β-islet CD4+ T cell affinity, and limits CD8 cross-priming and diabetes risk without presenting the cognate MHC-II islet self-antigen.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Huseby, E. S. & Teixeiro, E. The perception and response of T cells to a changing environment are based on the law of initial value. Sci. Signal. 15, eabj9842 (2022). A review article that highlights the role of self-peptide MHC recognition in T cell development.
Todd, J. A. et al. A molecular basis for MHC class II-associated autoimmunity. Science 240, 1003–1009 (1988). This paper reports that MHC-II polymorphisms influence T1D susceptibility.
Hu, X. et al. Additive and interaction effects at three amino acid position in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat. Genet. 47, 898–905 (2015). This paper reports that homozygous expression of MHC-II susceptibility alleles increases T1D risk.
Stadinski, B., Kappler, J. & Eisenbarth, G. S. Molecular targeting of islet autoantigens. Immunity 32, 446–456 (2010). A review article that presents the role of T cells and autoantigens in the T1D disease process.
Stadinski, B. D. et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat. Immunol. 17, 946–955 (2016). A paper that reports global changes in TCR CDR3 usage by self-reactive T cells.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Stadinski, B. D. et al. I-Ag7 β56/57 polymorphisms regulate non-cognate negative selection to CD4+ T cell orchestrators of type 1 diabetes. Nat. Immunol. https://doi.org/10.1038/s41590-023-01441-0 (2023).
Rights and permissions
About this article
Cite this article
MHC-II heterozygosity limits type 1 diabetes susceptibility through negative selection. Nat Immunol 24, 573–574 (2023). https://doi.org/10.1038/s41590-023-01446-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-023-01446-9
